http://investors.merck.com/news/pre...stat-with-KEYTRUDA-pembrolizumab/default.aspx
Sorry my status should say I hold VLA stock and will keep holding. This is not great as they advance with other items, but I guess it also shows that VLA could advance into neck/brain etc as well. Data will decide, hope all is still good.
- Forums
- ASX - By Stock
- VLA
- Merck and Incyte article